FDA approves Abbott's spinal cord stimulation system for chronic pain — 4 insights

Spinal Tech

Abbott received FDA approval for Proclaim XR, a neurostimulation device for people suffering from chronic pain.

Four insights:

1. Proclaim XR is a recharge-free platform that provides a low dose of Abbott's BurstDR stimulation waveform, which copies natural patterns found in the brain.

2. The low dose electric pulses transform pain signals as they travel from the spinal cord to the brain.

3. Proclaim XR has a battery life of up to 10 years.

4. The device also uses Apple mobile software and Bluetooth technology to help manage pain.

More articles on devices:
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change
Dr. Timothy Kremchek to operate on Reds rookie Nick Senzel — 4 insights
Icotec to introduce new pedicle screw system — 4 insights 



Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers